Teladoc Health charged one of its biggest telehealth rivals, United states Well Corp., of patent violation in a lawsuit filed Monday.
The lawsuit submitted in a Delaware federal court claims that Amwell has infringed upon patents developed by InTouch Health, the telehealth company that Teladoc obtained in July.
“As a result of Amwell’s infringement of the asserted patents, Teladoc has suffered and will continue to suffer problems, ” Teladoc’s complaint reads.
Six of Amwell’s products—four telehealth carts, a digital range system and a digital stethoscope—infringe upon nine patents developed by Touch Health’s founder Yulun Wang, the issue alleges. In total, InTouch Health includes a portfolio of more than 130 patents plus patent applications, according to the complaint.
Teladoc argues Amwell has already established knowledge of the alleged patent violation since at least Sept. 14, whenever counsel for Teladoc sent the letter notifying the company of the 9 patents.
Amwell on Sept. 15 acknowledged Teladoc’s letter in an amended S-1 submitting with the Securities plus Exchange Commission.
“While we can provide no ensures about the outcome of any potential question, we believe that these claims absence merit and, if Teladoc efforts to bring these claims to court, all of us intend to defend against them vigorously, inch Amwell’s filing reads.
Revenue from Amwell’s gadgets and technology business, which includes the items mentioned in Teladoc’s lawsuit, made up just 5% of Amwell’s 2019 revenue, according to the filing.
A Teladoc spokesperson within a statement said that Teladoc is “confident that AmWell is infringing for the patents identified in the lawsuit. inch
Amwell failed to immediately respond to a request for remark.
Amwell, that is backed by Google , proceeded to go public Sept. 17, closing on $23. 07 its first time of public trading. The company shut Monday at $34. 71; since press time, its stock cost was $34. 73.
Teladoc closed Monday with $218; as of press time, the stock price was $232. thirty four.
Teladoc in the lawsuit is seeking monetary problems from Amwell as well as for Amwell to prevent the alleged infringement on the patents.
This particular lawsuit isn’t the first time Teladoc plus Amwell have been involved in an obvious dispute.
Within 2015, Amwell filed an obvious infringement lawsuit against Teladoc in the Massachusetts federal court, alleging Teladoc used a similar method to connect sufferers with physicians. The lawsuit has been dismissed a year afterwards with a federal judge calling Amwell’s patent invalid, after ruling facets of the patent were too summary.